Molecular and clinical characterization of Galectin‐9 in glioma through 1,027 samples

In recent years, research on glioma immunotherapy have grown rapidly. However, the autoimmune‐like side effects that are caused by blocking immunological checkpoints hinder their clinical application in gliomas currently. Galectin‐9, a ligand for T‐cell immunoglobulin mucin 3, has shed a new light o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cell Physiol
Autors principals: Yuan, Feng, Ming, Haolang, Wang, Yingshuai, Yang, Yihan, Yi, Li, Li, Tao, Ma, Haiwen, Tong, Luqing, Zhang, Liang, Liu, Peidong, Li, Jiabo, Lin, Yu, Yu, Shengping, Ren, Bingcheng, Yang, Xuejun
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Original Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7028024/
https://ncbi.nlm.nih.gov/pubmed/31609000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcp.29309
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars